Menu
Back to User profile » Professor Kenneth R Chapman
Papers published by Professor Kenneth R Chapman:
Association of Obstructive Apnea with Thoracic Fluid Shift and Small Airways Narrowing in Asthma During Sleep
Cao X, de Oliveira Francisco C, Bradley TD, Montazeri Ghahjaverestan N, Tarlo SM, Stanbrook MB, Chapman KR, Inman M, Yadollahi A
Nature and Science of Sleep 2022, 14:891-899
Published Date: 6 May 2022
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
Pavord ID, Chapman KR, Bafadhel M, Sciurba FC, Bradford ES, Schweiker Harris S, Mayer B, Rubin DB, Yancey SW, Paggiaro P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1755-1770
Published Date: 16 June 2021
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
Wise RA, Chapman KR, Scirica BM, Daoud SZ, Lythgoe D, Garcia-Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:689-699
Published Date: 18 March 2021
The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
Leung C, Bourbeau J, Sin DD, Aaron SD, FitzGerald JM, Maltais F, Marciniuk DD, O'Donnell D, Hernandez P, Chapman KR, Walker B, Road JD, Zheng L, Zou C, Hogg JC, Tan WC
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:305-320
Published Date: 12 February 2021
Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
Kaplan A, Chapman KR, Anees SM, Mayers I, Rochdi D, Djandji M, Préfontaine D, McIvor A
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:249-260
Published Date: 18 January 2019
Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1125-1134
Published Date: 10 April 2018
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:419-432
Published Date: 31 January 2018
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
Miravitlles M, Chapman KR, Chuecos F, Ribera A, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2041-2053
Published Date: 29 August 2016
Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
D’Urzo AD, Kerwin EM, Chapman KR, Decramer M, DiGiovanni R, D’Andrea P, Hu H, Goyal P, Altman P
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1599-1612
Published Date: 11 August 2015
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease
Ribeiro M, Chapman KR
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:145-152
Published Date: 5 March 2012